• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Redx Oncology

Goldilocks three bears story fairy tale fables
Biotech

AstraZeneca drops GOLDILOX and the porcupine in R&D update

The drugmaker axed a cardiovascular disease prospect while stopping work on early-stage assets bought in from Ionis and Redx Pharma.
Nick Paul Taylor Apr 25, 2024 3:24am
deal handshake business cooperation partnerships

Jazz jumps into KRAS G12D space via $10M upfront deal with Redx

Feb 7, 2024 8:30am
MA

Jounce jilts Redx for Concentra's surprise merger offer

Mar 27, 2023 10:56am
Pac man eat MA deal buy sell merger

Biotech makes surprise bid to snatch Jounce out of Redx's hands

Mar 15, 2023 8:48am
porcupine balloon tough spot difficult hard

Redx stung by porcupine inhibitor flop in biliary tract cancer

Mar 8, 2023 10:30am
MA

Jounce lays off 57% of staff, agrees reverse merger with Redx

Feb 23, 2023 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings